Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis

Fujii, 2012, Inflammation and fibrogenesis in steatohepatitis, J Gastroenterol, 47, 215, 10.1007/s00535-012-0527-x Luedde, 2014, Cell death and cell death responses in liver disease: mechanisms and clinical relevance, Gastroenterology, 147, 765, 10.1053/j.gastro.2014.07.018 Amir, 2011, Autophagy in nonalcoholic steatohepatitis, Expert Rev Gastroenterol Hepatol, 5, 159, 10.1586/egh.11.4 Guicciardi, 2013, Apoptosis and necrosis in the liver, Compr Physiol, 3, 977, 10.1002/cphy.c120020 Linkermann, 2014, Necroptosis. N Engl J Med, 370, 455, 10.1056/NEJMra1310050 Chen, 2014, Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death, Cell Res, 24, 105, 10.1038/cr.2013.171 Cai, 2014, Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis, Nature Cell Biol, 16, 55, 10.1038/ncb2883 Dillon, 2012, Survival function of the FADD-CASPASE-8-cFLIP(L) complex, Cell Reports, 1, 401, 10.1016/j.celrep.2012.03.010 Liedtke, 2011, Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury, Gastroenterology, 141, 2176, 10.1053/j.gastro.2011.08.037 Kaufmann, 2009, Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim, Immunity, 30, 56, 10.1016/j.immuni.2008.10.017 Miao, 2011, Caspase-1-induced pyroptotic cell death, Immunol Rev, 243, 206, 10.1111/j.1600-065X.2011.01044.x Rathinam, 2012, Regulation of inflammasome signaling, Nat Immunol, 13, 333, 10.1038/ni.2237 Shi, 2014, Inflammatory caspases are innate immune receptors for intracellular LPS, Nature, 514, 187, 10.1038/nature13683 Kubes, 2012, Sterile inflammation in the liver, Gastroenterology, 143, 1158, 10.1053/j.gastro.2012.09.008 Yamada, 2014, Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis, Liver Int Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655 Listenberger, 2003, Triglyceride accumulation protects against fatty acid-induced lipotoxicity, Proc Natl Acad Sci USA, 100, 3077, 10.1073/pnas.0630588100 de Almeida, 2002, Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis, Clin Nutr, 21, 219, 10.1054/clnu.2001.0529 Han, 2008, Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes, J Lipid Res, 49, 84, 10.1194/jlr.M700184-JLR200 Kakisaka, 2012, Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis, Am J Physiol Gastrointest Liver Physiol, 302, G77, 10.1152/ajpgi.00301.2011 Alkhouri, 2011, Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications, Expert Rev Gastroenterol Hepatol, 5, 201, 10.1586/egh.11.6 Feldstein, 2003, Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis, Gastroenterology, 125, 437, 10.1016/S0016-5085(03)00907-7 Puri, 2008, Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease, Gastroenterology, 134, 568, 10.1053/j.gastro.2007.10.039 Cazanave, 2011, Death receptor 5 signaling promotes hepatocyte lipoapoptosis, J Biol Chem, 286, 39336, 10.1074/jbc.M111.280420 Lu, 2014, Cell death. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis, Science, 345, 98, 10.1126/science.1254312 Wei, 2006, Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells, Am J Physiol Endocrinol Metab, 291, E275, 10.1152/ajpendo.00644.2005 Cazanave, 2010, CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis, Am J Physiol Gastrointest Liver Physiol, 299, G236, 10.1152/ajpgi.00091.2010 Barreyro, 2007, Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis, J Biol Chem, 282, 27141, 10.1074/jbc.M704391200 Akazawa, 2010, Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis, J Hepatol, 52, 586, 10.1016/j.jhep.2010.01.003 Ashkenazi, 1999, Safety and antitumor activity of recombinant soluble Apo2 ligand, J Clin Invest, 104, 155, 10.1172/JCI6926 Malhi, 2007, Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity, Gut, 56, 1124, 10.1136/gut.2006.118059 Hirsova, 2013, Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis, PLoS One, 8, e70599, 10.1371/journal.pone.0070599 Volkmann, 2007, Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver, Hepatology, 46, 1498, 10.1002/hep.21846 Idrissova L, Malhi H, Werneburg NW, et al. Trail receptor deletion in mice suppresses the inflammation of nutrient excess. J Hepatol. Published online. http://dx.doi.org/10.1016/j.jhep.2014.11.033. Feldstein, 2003, Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice, J Hepatol, 39, 978, 10.1016/S0168-8278(03)00460-4 Siebler, 2007, Enhanced sensitivity to CD95-induced apoptosis in ob/ob mice, Dig Dis Sci, 52, 2396, 10.1007/s10620-006-9148-7 Zou, 2007, Lack of Fas antagonism by Met in human fatty liver disease, Nat Med, 13, 1078, 10.1038/nm1625 Crespo, 2001, Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, Hepatology, 34, 1158, 10.1053/jhep.2001.29628 Ribeiro, 2004, Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients, Am J Gastroenterol, 99, 1708, 10.1111/j.1572-0241.2004.40009.x Feldstein, 2004, Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway, Hepatology, 40, 185, 10.1002/hep.20283 Li, 2003, Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, Hepatology, 37, 343, 10.1053/jhep.2003.50048 Memon, 2001, TNF-alpha is not the cause of fatty liver disease in obese diabetic mice, Nat Med, 7, 2, 10.1038/83316 Sun, 1999, RIP3, a novel apoptosis-inducing kinase, J Biol Chem, 274, 16871, 10.1074/jbc.274.24.16871 Csak, 2011, Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice, Hepatology, 53, 1917, 10.1002/hep.24301 Gautheron, 2014, A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis, EMBO Mol Med, 6, 1062, 10.15252/emmm.201403856 Hatting, 2013, Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents, Hepatology, 57, 2189, 10.1002/hep.26271 Barreyro, 2014, The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis, Liver Int Witek, 2009, Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis, Hepatology, 50, 1421, 10.1002/hep.23167 Dixon, 2013, Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis, PLoS One, 8, e56100, 10.1371/journal.pone.0056100 Wree, 2014, NLRP3 inflammasome activation is required for fibrosis development in NAFLD, J Mol Med (Berl), 92, 1069, 10.1007/s00109-014-1170-1 Wree, 2014, NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice, Hepatology, 59, 898, 10.1002/hep.26592 Silvestre-Roig, 2014, Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies, Circ Res, 114, 214, 10.1161/CIRCRESAHA.114.302355 Chu, 2013, Tumor necrosis factor, Cancer Lett, 328, 222, 10.1016/j.canlet.2012.10.014 Azijli, 2013, Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family, Cell Death Differ, 20, 858, 10.1038/cdd.2013.28 Azijli, 2012, Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells, J Cell Sci, 125, 4651, 10.1242/jcs.109587 Collison, 2009, Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses, Clin Exp Pharmacol Physiol, 36, 1049, 10.1111/j.1440-1681.2009.05258.x Cullen, 2013, Fas/CD95-induced chemokines can serve as “find-me” signals for apoptotic cells, Mol Cell, 49, 1034, 10.1016/j.molcel.2013.01.025 Marra, 2014, Roles for chemokines in liver disease, Gastroenterology, 147, 577, 10.1053/j.gastro.2014.06.043 Andaloussi, 2013, Extracellular vesicles: biology and emerging therapeutic opportunities, Nat Rev Drug Discov, 12, 347, 10.1038/nrd3978 Canbay, 2003, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, Hepatology, 38, 1188, 10.1053/jhep.2003.50472 Povero, 2013, Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells, Sci Signal, 6, ra88, 10.1126/scisignal.2004512 Bretz, 2013, Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling, J Biol Chem, 288, 36691, 10.1074/jbc.M113.512806 Racanelli, 2006, The liver as an immunological organ, Hepatology, 43, S54, 10.1002/hep.21060 De Vito, 2012, Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease, Int J Mol Med, 30, 49 Miura, 2012, Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2, Am J Physiol Gastrointest Liver Physiol, 302, G1310, 10.1152/ajpgi.00365.2011 Tosello-Trampont, 2012, Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production, J Biol Chem, 287, 40161, 10.1074/jbc.M112.417014 Guebre-Xabier, 2000, Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage, Hepatology, 31, 633, 10.1002/hep.510310313 Li, 2005, Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease, Hepatology, 42, 880, 10.1002/hep.20826 Yang, 2007, Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers, Lab Invest, 87, 927, 10.1038/labinvest.3700603 Syn, 2010, Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease, Hepatology, 51, 1998, 10.1002/hep.23599 Wolf, 2014, Metabolic activation of intrahepatic CD8(+) T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes, Cancer Cell, 26, 549, 10.1016/j.ccell.2014.09.003 Kumar, 2013, NKT-cell subsets: promoters and protectors in inflammatory liver disease, J Hepatol, 59, 618, 10.1016/j.jhep.2013.02.032 Henning, 2013, Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice, Hepatology, 58, 589, 10.1002/hep.26267 Tacke, 2013, From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver, Hepatology, 58, 494, 10.1002/hep.26405 Argo, 2009, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019 Canbay, 2004, Apoptosis: the nexus of liver injury and fibrosis, Hepatology, 39, 273, 10.1002/hep.20051 Canbay, 2003, Apoptotic body engulfment by a human stellate cell line is profibrogenic, Lab Invest, 83, 655, 10.1097/01.LAB.0000069036.63405.5C Povero, 2013, Hepatocytes-derived microparticles released during lipotoxicity induce hepatic stellate cells activation and migration, Hepatology, 58, S574A Thapaliya, 2014, Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model, Dig Dis Sci, 59, 1197, 10.1007/s10620-014-3167-6 Canbay, 2004, The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse, J Pharmacol Exp Ther, 308, 1191, 10.1124/jpet.103.060129 Anstee, 2010, Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis, J Hepatol, 53, 542, 10.1016/j.jhep.2010.03.016 Ratziu, 2012, A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis, Hepatology, 55, 419, 10.1002/hep.24747 Csak, 2011, Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 54, 133, 10.1002/hep.24341 Dixon, 2012, Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis, Lab Invest, 92, 713, 10.1038/labinvest.2012.45 Kamari, 2011, Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice, J Hepatol, 55, 1086, 10.1016/j.jhep.2011.01.048 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Braddock, 2004, Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention, Nat Rev Drug Discov, 3, 330, 10.1038/nrd1342